|Day Low/High||141.23 / 143.97|
|52 Wk Low/High||109.16 / 157.00|
TheStreet's Jim Cramer says some biotech companies could be in play after the end of the deal between Pfizer and Allergan.
Shares of the pharmaceutical company are headed in the right direction, but the pace of the rally is slowing.
Pfizer scored the top spot in Interbrand Health's inaugural ranking of the top ten biopharmaceutical brands.
Heading into the second quarter, TheStreet's Jim Cramer believes stocks might be a little bit cheaper than investors realize, including Johnson & Johnson (JNJ), IBM (IBM) and Alphabet (GOOG).
Medivation is surging as Wall Street scouts the Big Pharma front for discounted M&A opportunities.
As Johnson & Johnson surveys the M&A scene, investors would be wise to keep Stryker on their radars, Real Money's Jim Cramer says.
TheStreet's Jim Cramer said Valeant Pharmaceuticals' (VRX) move to appoint billionaire investor Bill Ackman to the board of directors isn't enough and a government monitor is needed.
TheStreet's Jim Cramer says Gilead (GILD) needs to make an acquisition to jump start its business.
TheStreet’s Jim Cramer commented on United Airlines and JetBlue on Tuesday from the floor of the New York Stock Exchange.
I'm closing this trade as the gain/profit target has been met.
Microsoft’s stock eclipsed the $50 barrier last fall for the first time since March 2000.
It seems to be coming down to Hillary Clinton and Donald Trump, and both would be positive for business.
Jim Cramer says consumer products companies like Clorox, PepsiCo, and Procter & Gamble have the best stock charts right now.
Finding stocks that are caught in the market vortex but shouldn't be going down is the key to coming out a winner.
Janet Yellen's Congressional hearing and volatile oil prices are not enough to hurt the stock market.
U.S. futures look to build off of Tuesday's afternoon rally.
As we're talking ourselves into a recession, pressures on executives increase.
Janet Yellen and her colleagues should listen to companies' conference calls.
Wall Street roared back Tuesday as crude oil prices bounced higher and several companies reported strong earnings.
Despite another drop in Chinese equities, copper and zinc have rallied more than 2%.
Along came quality earnings from a few solid companies and the narrative changed.
But it takes time for good charts to develop, and we are still struggling to establish a solid low.